7 annual accounts with figures on one time axis, 21 filings since 1992
peak of €247,351 in 2012
€247,351▲ 60.2%
peak of €45,063 in 2012
€45,063▲ 31×
peak of €214,859 in 2012
€214,859▲ 26.5%
€625,112▼ 1.2%
peak of 2 FTE in 2012
2 FTE▲ 11.1%
Owners
100%Hidden nameVisible after signing in
Documentsfilings and deeds
23-07-2013filed
2012financial year
Gross margin from €154,439 to €247,351Result from €1,448 to €45,063Staff from 1.8 FTE to 2 FTE2 directors reappointed28-12Amendment of the articles02-02Equity from €169,796 to €214,859
Key points
from the 2012 annual accounts, the last ones filed
Merger: absorbed by IMVALCOIMVALCO holds all the shares · IMVALCO holds 125 shares (100%) · General meeting of 17-06-2013 · Gazette deed
Demerger proposal: REMEDIUM splits off to IMVALCO
Gazette deed
2 directors reappointedName after signing inVisible after signing in and IMVALCO · Name hiddenVisible after signing in acts as permanent representative · General meeting of 25-10-2012 · Gazette deed
Amendment of the articles
Capital €62,000, annual accounts 2012 · Gazette deed
Absorbed by IMVALCOmerger by absorption, July 2013
Activity
“La société a pour objet, tant en Belgique qu'à l'étranger, l'exploitation d'officines de pharmacie…” (deed in French)From the articles, 2 activitiesNo NACE code in the KBO